ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.430,05
1,42%
S&P 500
5.187,70
0,13%
Dow Jones
38.884,26
0,08%
Euro vs US Dollar
1,07564
-0,10%
Bitcoin
63.151,99
-0,02%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Homology Medicines Inc (FIXX)

  7. Homology Medicines Inc (FIXX) News

FIXX

Homology Medicines (FIXX)

Homology Medicines Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FIXX
DatumZeitQuelleÜberschriftSymbolFirma
18/03/202421h30GlobeNewswire Inc.Homology Medicines Declares Distribution to Common StockholdersNASDAQ:FIXXHomology Medicines Inc
11/03/202412h37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
11/03/202412h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FIXXHomology Medicines Inc
21/02/202422h04Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
15/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FIXXHomology Medicines Inc
13/02/202416h11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FIXXHomology Medicines Inc
05/01/202423h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
05/01/202423h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
03/01/202422h29Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
03/01/202422h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FIXXHomology Medicines Inc
03/01/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
03/01/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
03/01/202422h08GlobeNewswire Inc.Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price DeficiencyNASDAQ:FIXXHomology Medicines Inc
11/12/202322h15Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FIXXHomology Medicines Inc
17/11/202322h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
16/11/202322h19Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
16/11/202322h16Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
16/11/202322h13Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
16/11/202313h46Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
16/11/202313h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FIXXHomology Medicines Inc
16/11/202313h17Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
16/11/202313h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FIXXHomology Medicines Inc
16/11/202313h05GlobeNewswire Inc.Q32 Bio and Homology Medicines Announce Merger AgreementNASDAQ:FIXXHomology Medicines Inc
16/11/202313h05PR Newswire (US)Q32 Bio and Homology Medicines Announce Merger AgreementNASDAQ:FIXXHomology Medicines Inc
14/11/202322h33GlobeNewswire Inc.Homology Medicines Reports Third Quarter 2023 Financial ResultsNASDAQ:FIXXHomology Medicines Inc
10/10/202323h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FIXXHomology Medicines Inc
08/09/202322h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
14/08/202322h05GlobeNewswire Inc.Homology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
14/08/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FIXXHomology Medicines Inc
08/08/202303h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:FIXX

Kürzlich von Ihnen besucht

NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
USOTC
BNPQY
BNP Paribas (QX)
NYSE
KO
Coca Cola
TG
BAS
BASF
NYSE
JPM
JP Morgan Chase
DBI
MDAX
MDAX
AMEX
XLE
Energy Select Sector SPDR
DBI
SDXP
SDAX
NASDAQ
AMZN
Amazon.com
USOTC
RHHBY
Roche (QX)
NYSE
MRK
Merck
TG
DTE
Deutsche Telekom
AMEX
XLV
Health Care Select Sector
TG
TUI1
Tui
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten